• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Citrus Support for the Blood Glucose-Immune System Connection

    A Glance At The Eye Health Market

    The Value of Vitamin D Testing

    A Growing Need for Mineral Supplementation

    More Than Just A Trend: Supplements Embedded in Consumer Health Regimens
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet

    Gadot Positions Mineral Line for Vegan Market

    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition

    FrieslandCampina Launches Biotis Immune Health Ingredient

    Astaxanthin Microencapsulated with Spirulina Targets ‘Mental Agility’ and Healthy Aging
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Gadot Positions Mineral Line for Vegan Market

    FrieslandCampina Launches Biotis Immune Health Ingredient

    Astaxanthin Microencapsulated with Spirulina Targets ‘Mental Agility’ and Healthy Aging

    Ingredient Manufacturers Discuss the E-Sports Market

    Study Highlights Differences Between EPA's and DHA's Effect on Sleep
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet

    Gadot Positions Mineral Line for Vegan Market

    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition

    FrieslandCampina Launches Biotis Immune Health Ingredient

    Ingredient Manufacturers Discuss the E-Sports Market
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet

    FrieslandCampina Launches Biotis Immune Health Ingredient

    Astaxanthin Microencapsulated with Spirulina Targets ‘Mental Agility’ and Healthy Aging

    Ingredient Manufacturers Discuss the E-Sports Market

    Euromonitor Names Top Ten Trends for 2021
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Vesta Nutra

    Sabinsa Corporation

    Bioenergy Life Science, Inc. (BLS)

    KLK OLEO - Davos Life Science

    Aiya America (Matcha by Aiya)
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Sabinsa Corporation

    Nutrition21, LLC

    Aiya America (Matcha by Aiya)

    Bioenergy Life Science, Inc. (BLS)

    Indena USA, Inc.
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Regulatory Review: 20 Years Since DSHEA

    The I-Health/Martek consent decree should be a wake-up call for the natural products industry.

    Regulatory Review: 20 Years Since DSHEA
    Regulatory Review: 20 Years Since DSHEA
    Related CONTENT
    • NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    • High-Protein Meal Replacement Improves Exercise Metabolism Compared to Standard Breakfast
    • FDA Warns Against Male Enhancement and Weight Loss Products Sold Online
    • Brain Health: A Mysterious Frontier
    • DASH Diet Has No Protective Association With Sarcopenia, Study Finds
    Todd Harrison, Venable09.01.14
    With the 20th anniversary of the passage of the Dietary Supplement Health and Education Act (DSHEA), there remains a significant amount of angst within the industry regarding its direction and whether the current regulatory structure serves the best interest of the industry and the general public.

    Certainly, DSHEA was necessary in 1993 to ensure the availability of dietary supplements. However, the Internet was still in its infancy and no one could have foreseen the explosion of information and products that it would fuel. Access to so much information allows consumers to research products and ingredients to determine their own action plan for not only maintaining overall health and well-being but also for reducing their risk of becoming ill or to treat minor conditions such as a cold-related cough or minor aches and pains related to arthritis. The flip side of having all this information at your fingertips is that we now have products that purport to treat whatever ails you.   

    Unfortunately, the present regulatory structure could not have foreseen the impact that a nearly non-existent barrier of entry would mean to the industry or to the consumer. For the industry, it has fueled the perception by those in the mass media, politicians and regulators that we are a rogue industry that needs to be watched because we cannot be trusted. For the consumer, it has meant confusing or misleading structure/function claims, as well as being bombarded with fraudulent products promising miracle cures for arthritis, dementia and unlimited weight loss. It has also spawned a cottage industry of plaintiff attorneys, who believe the natural products industry is an easy target for their manufactured lawsuits; unfortunately, these attorneys understand that the rogue Internet player amounts to no more than a game of hide and seek, so instead they pursue legitimate companies. 

    Recently, we have seen this scenario played out on the national stage. While the Senate hearing featuring Dr. Oz received a significant amount of attention, the distrust of the regulator was played out behind the scenes with the I-Health/Martek consent decree. This consent decree is a travesty and should be rescinded, as neither company did anything wrong and its study and findings are legitimate.

    Easy Market Access
    Let’s first address an issue that the industry understands but ignores: the ease with which someone can bring any product to the marketplace. In this regard, the Senate hearing had some legitimacy, however, the senators were more interested in scoring points and making Dr. Oz and the industry look bad; it either failed to understand or appreciate the issue, which is the easy access to stock products. Certain ingredients referenced in the hearing actually have good clinical studies to support the basic weight loss claim. However, the hearing failed to recognize that many of those ingredients are branded and the products being sold are cheap knock offs offered by contract manufacturers to rogue fly-by-night Internet marketers that are often only one or two people looking to get rich quick. These are not real Internet companies that sell legitimate products in the digital marketplace. Let me offer an example.

    I can wake up tomorrow and decide I want to market a dietary supplement for weight loss. Within 30 minutes (probably quicker), I can find a contract manufacturer (one that carries third-party certifications and belongs to all the right trade associations) that will offer me its generic stock weight loss product for a reasonable cost. I can probably get delivery within 30 days of ordering the product. The product will generally not contain a branded ingredient nor will the ingredient be substantially equivalent. To the extent the ingredient(s) are substantially equivalent, the product is generally full of unsubstantiated levels of the ingredients. I call this  “pixie dusting.”

    Yet, the contract manufacturer is representing to me as a potential customer that this product is a weight loss product. Now, if I am a novice, I would simply get my e-commerce site that is loaded with questionable claims of efficacy and marketing practices up and running. It really is that simple. However, industry either seems unwilling or at a loss for how to address this practice. Besides changing DSHEA to require mandatory product listing (I am against mandatory, but do not have an issue with voluntary), there is a self-regulatory approach that will help address this situation. 

    More particularly, there are numerous organizations and/or entities that promote third-party certification processes. However, none of these certifiers appear to address whether a contract manufacturer’s stock formula (that is sold to any private-label distributor willing to buy it) has adequate substantiation for the formula. Yet, the contract manufacturer is using these certifications to prove it’s bona fide to the potential customer. These certifiers should add substantiation of stock products to the certification process and require adequate substantiation for a stock formula to receive/retain certification.

    Will this approach eliminate the practice? Of course not, but it is a start. This is only one potential solution to the issue and I am sure there are many others. However, if the problem is not addressed, then the answer may be to require all companies manufacturing and marketing products to list their products with FDA, and it be a violation for a contract manufacturer to produce a product for a private-label distributor that has not been listed with FDA within 30 days of first marketing its product.

    I have one word of caution to those contract manufacturers that regularly sell to questionable companies: FTC may decide to forego the rogue Internet marketer and attempt to hold you responsible for being part of the supply chain. Thus, contract manufacturers should conduct their own due diligence on potential customers and not sell to companies with highly questionable business tactics.

    Clinical Substantiation
    Now, let’s discuss another serious issue within the industry: the value of clinical trials. I am a big proponent of conducting clinical trials on ingredients and finished products. I believe it is absolutely necessary to bring legitimacy to the industry. However, FTC’s consent decree with I-Health and Martek has sent a chill down my back and should send one down yours. The belief by FTC that Martek’s study was not sufficient to support I-Health’s marketing claim leaves me dumbfounded and is a classic situation of the government substituting its expert opinion for that of the company’s. Oddly, outside of the Organic and Natural Health Association (ONHA), a new industry trade group that includes consumer members, the industry was relatively quiet on this consent decree even though its potential chilling effect is significant. In filing comments, ONHA urged the commissioners to reconsider placing I-Health/Martek under order because of its potential effect on future studies. (Out of full disclosure, Venable drafted the comments for ONHA and I am serving as the initial president of the new association.)

    More specifically, ONHA stated: “if the Commission pursues an enforcement action against the Companies based upon questioning the analysis in the published MIDAS Study, it will establish a regulatory paradigm that will adversely affect consumers because advertisers will refrain from providing truthful and nonmisleading information about their products for fear of government prosecution. While the Commission has authority to prohibit false and misleading advertising, if it were to continue to construe the substantiation standard to punish the Companies for making these claims and prohibit further communications to consumers, it would trample the First Amendment by suppressing claims in advertisements that are backed by a randomized, peer-reviewed and published clinical study.”

    Moreover, ONHA noted that the proposed consent decree would “likely have the perverse effect of disincentivizing advertisers from spending the time, money, and resources required to develop clinical studies to support their claims.” In short, is there any clinical study that the FTC would find substantiates a product claim? I have my doubts, but I also believe that upgrading DSHEA can help address this issue. 

    More specifically, I have long been an advocate of permitting disease claims for dietary supplement products that are consistent with FDA’s OTC Drug Monograph system. I have further urged that such claims should be permitted if a clinical study is conducted on the targeted product and submitted to FDA. In fact, we could create a regulatory framework that would permit companies and FDA to work with each other to develop studies that are well-conducted.

    In this regard, I would urge Congress to change the law to permit clinical studies on dietary supplements for disease conditions outside of the investigational new drug process. I would further modify the law to permit a company to submit a protocol to FDA for its review and comments on the design of the study. Congress could include a user fee for the protocol review process. The user fee could be set to be no more than $2,500 and have a sliding scale based on the size of the company. Finally, once the protocol is finalized and the study is conducted, the company should be permitted to make claims based on the study outcomes. Those marketing claims would not be subject to attack by FTC because it disagrees the study was appropriately conducted since FDA already approved the study. 

    This process is similar to one in Canada and would encourage the performance of clinical studies. Yes, the details need to be filled in and would be the subject of negotiations, but ultimately, having a meaningful regulatory structure regarding clinical studies and claims based thereon serves the industry well and will have the added benefit of limiting plaintiff class-action lawsuits.

    The purpose is not to require clinical studies for all products, but only for those companies desiring to make a disease claim for their product or looking for a safe harbor for their structure/function claim. I also believe we need a natural products monograph system for products that make cough/cold type claims because it is an utter waste of agency resources to send a warning letter over whether a cough/cold claim is an impermissible disease claim.         


    Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.
    Related Searches
    • Contract Manufacturer
    • Organic
    • Performance
    • Dietary Supplements
    Related Knowledge Center
    • Quality & Safety
    • Contract Manufacturing
    • Natural/Organic
    Suggested For You
    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    High-Protein Meal Replacement Improves Exercise Metabolism Compared to Standard Breakfast High-Protein Meal Replacement Improves Exercise Metabolism Compared to Standard Breakfast
    FDA Warns Against Male Enhancement and Weight Loss Products Sold Online FDA Warns Against Male Enhancement and Weight Loss Products Sold Online
    Brain Health: A Mysterious Frontier Brain Health: A Mysterious Frontier
    DASH Diet Has No Protective Association With Sarcopenia, Study Finds DASH Diet Has No Protective Association With Sarcopenia, Study Finds
    Preliminary Evidence Supports Lipoic Acids as Weight Loss Ingredient Preliminary Evidence Supports Lipoic Acids as Weight Loss Ingredient
    Arla Foods Predicts Trend of High-Protein Iced Tea Arla Foods Predicts Trend of High-Protein Iced Tea
    National Advertising Division Refers Company to FTC Over Dramatic Weight Loss Claims National Advertising Division Refers Company to FTC Over Dramatic Weight Loss Claims
    Pilot Study Suggests Fiber, Mineral Formulation May Offer Benefits for Overweight Women  Pilot Study Suggests Fiber, Mineral Formulation May Offer Benefits for Overweight Women
    Metabolic Health: It’s All About Insulin Metabolic Health: It’s All About Insulin
    Understanding FTC Standards for Claims Substantiation Understanding FTC Standards for Claims Substantiation
    Transforming Health with Nature’s Sunshine Transforming Health with Nature’s Sunshine
    TREHA Trehalose Available As ‘Natural Flavor’ TREHA Trehalose Available As ‘Natural Flavor’
    ConsumerLab.com Tests Popular Vitamin D Supplements ConsumerLab.com Tests Popular Vitamin D Supplements
    Gottlieb Confirmed to Lead FDA Gottlieb Confirmed to Lead FDA

    Related Columns

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      The Off-Label On Ramp

      The Off-Label On Ramp

      With an expanding base of clinical research supporting nutritional interventions, off label use of dietary supplements and medical foods is likely to grow.
      By Gregory Stephens, Windrose Partners, and Sheila Campbell, PhD, RD 01.19.21

    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations
      ‘Follow the Science’ Often Misses the Mark with Nutrition

      ‘Follow the Science’ Often Misses the Mark with Nutrition

      The mantra too often ignores common sense approaches to improving health and quality of life.
      By Todd Harrison, Venable 01.19.21

    • Dietary Supplements | Herbs & Botanicals | Regulations | World Markets
      CBD in Europe: News from the Front

      CBD in Europe: News from the Front

      A recent decision by the Court of Justice of the European Union has restored CBD’s status, and with it, the prospects of the entire industry.
      By Joerg Gruenwald, analyze & realize ag 01.19.21


    • Delivery & Dosage Technologies | Dietary Supplements | Herbs & Botanicals | Quality & Safety
      The Advantages of Organic, Broad Spectrum Hemp

      The Advantages of Organic, Broad Spectrum Hemp

      Mike Hennesy, Wana Brands, discusses the company’s new gummies, innovation, and continuing market evolution.
      By Sheldon Baker 12.04.20

    • Dietary Supplements | Regulations
      Insurance Rates Have Been at an All-Time Low, But a Hard Market is Coming

      Insurance Rates Have Been at an All-Time Low, But a Hard Market is Coming

      Companies can be prepared by being thorough and transparent while going through insurance policy renewals.
      By Chris Morey, Bolton & Company 12.04.20

    • Dietary Supplements | Regulations
      A Business Perspective on Protecting Confidential Information: The NDA

      A Business Perspective on Protecting Confidential Information: The NDA

      Along with taking precautions in providing access to confidential information, a non-disclosure agreement can be a great way to protect your business.
      By Gregory Stephens, Windrose Partners 11.09.20


    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations | Research | Vitamins
      Using All the Tools to Improve Public Health

      Using All the Tools to Improve Public Health

      Industry needs to make a stand in compelling authorities to communicate the value of nutrition and dietary supplementation.
      By Todd Harrison, Venable 11.09.20

    • Dietary Supplements | Regulations | World Markets
      Regulation Changes Calculus for Substance-Based Medical Devices

      Regulation Changes Calculus for Substance-Based Medical Devices

      The new regulation introduces more specific requirements for the technical documentation of this class of products.
      By Joerg Gruenwald, analyze & realize ag 11.09.20

    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations
      Federal Regulators Slam Doctors for COVID-Related Communications

      Federal Regulators Slam Doctors for COVID-Related Communications

      Some practitioners were not selling or promoting products, they were simply suggesting certain natural substances might offer benefits in improving resilience.
      By Erik Goldman, Holistic Primary Care 10.01.20


    • Delivery & Dosage Technologies | Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Pet Nutraceuticals
      CBD Dog Health and Fire Flake Farm: Holistic Healing for Furry Friends

      CBD Dog Health and Fire Flake Farm: Holistic Healing for Furry Friends

      Angela Ardolino is a certified cannabis specialist and holistic pet expert who has been caring for animals for over 20 years.
      By Sheldon Baker 10.01.20

    • Dietary Supplements | Regulations
      Nuance Claims? The Red Flags Around False Advertising, Intellectual Property & Mislabeling

      Nuance Claims? The Red Flags Around False Advertising, Intellectual Property & Mislabeling

      If you are a product formulator, label designer, or manufacturing facility, an Errors and Omissions policy is worth exploring.
      By Chris Morey, Bolton & Company 10.01.20

    • Dietary Supplements | Healthcare Trends | Research
      Spotlight on Clinical Research in the COVID-19 Era

      Spotlight on Clinical Research in the COVID-19 Era

      Discerning high quality research evidence from speculation and marketing hype is more important in today’s climate.
      By Greg Stephens, Windrose Partners, & Sheila Campbell, PhD, RD 09.08.20


    • Immune Function | Regulations | Research | Vitamins
      Nutritional Status Has Critical Implications for Public Health

      Nutritional Status Has Critical Implications for Public Health

      Vitamin D, N-acetyl cysteine, and quercetin may have important roles to play in this pandemic.
      By Todd Harrison, Venable 09.08.20

    • Herbs & Botanicals | Regulations | World Markets
      CBD Regulatory Status Update in Europe

      CBD Regulatory Status Update in Europe

      Investing in a novel food application for hemp extracts or CBD derived from hemp is a risky proposition at present.
      By Joerg Gruenwald, analyze & realize ag 09.08.20

    • Diabetes & Blood Sugar Management | Herbs & Botanicals | Immune Function | Quality & Safety | Research | Sports Nutrition | Testing
      Botanical Research: Medicinal  Mushrooms, Tart Cherry for Endurance, Nigella Sativa for Diabetes

      Botanical Research: Medicinal Mushrooms, Tart Cherry for Endurance, Nigella Sativa for Diabetes

      AHPA compiles recent research on botanicals and plant compounds published in peer-reviewed journals.
      By Holly Johnson, PhD, American Herbal Products Association (AHPA) 09.08.20

    Trending
    • Nutrition Industry Reacts To 2020-2025 Dietary Guidelines For Americans
    • Preliminary Study Suggests Link Between Omega-3s And Lower COVID-19 Death Rates
    • Maternal Dietary Intake Of Fish, Omega-3s, And Omega-6s Linked To Child Neurodevelopment
    • Mintel Announces Global Food And Drinks Trends For 2021
    • FrieslandCampina Launches Biotis Immune Health Ingredient
    Breaking News
    • NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    • Gadot Positions Mineral Line for Vegan Market
    • Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    • FrieslandCampina Launches Biotis Immune Health Ingredient
    • Astaxanthin Microencapsulated with Spirulina Targets ‘Mental Agility’ and Healthy Aging
    View Breaking News >
    CURRENT ISSUE

    Jan/Feb 2021

    • A Growing Need for Mineral Supplementation
    • The Value of Vitamin D Testing
    • A Glance At The Eye Health Market
    • Citrus Support for the Blood Glucose-Immune System Connection
    • Modern Snacking: Where Health & Indulgence Converge
    • More Than Just A Trend: Supplements Embedded in Consumer Health Regimens
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    Gadot Positions Mineral Line for Vegan Market
    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    Coatings World

    Latest Breaking News From Coatings World

    LINE-X Launches Dealer Program with International Truck
    PPG Reports Q4, Full-year 2020 Financial Results
    BASF Begins Implementing Ralignment of Global Business Services Unit
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex Companies CEO Steps Down
    Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread
    Endoscopic Hemostasis Devices Market Valued at $730 Million
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pfizer, BioNTech Enter Vax Pact with COVAX
    FDA Approves Janssen’s CABENUVA
    AGC Biologics Appoints Boulder Site GM
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Coty Appoints Chief Procurement Officer
    Lageen Tubes Launches Mono-Material PE Tube Solutions
    Jason Jones Loses Battle with Covid-19
    Happi

    Latest Breaking News From Happi

    Carol’s Daughter Adds New Hair Products
    Moroccan Gold Series Launches NuDo Shampoo
    Youbody Debuts Waterless Body Wash
    Ink World

    Latest Breaking News From Ink World

    BOBST Demonstrates Future of Flexible Packaging Production at Virtual Open House
    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    AR Packaging Acquiring Firstan Holdings Ltd
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Gallus planning virtual event for March
    Lemu Group engineers mask-making machine
    Niagara Label upgrades with Nilpeter flexo press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Freudenberg to Establish Apparel Interlining Competence Centers
    Minet Adds Spunlace Line in Romania
    Lemu Group Engineers Mask-Making Machine
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Cretex Companies CEO Steps Down
    Conformis Enters Development & Supply Agreement with SITES Medical
    Sectra, RSA Biomedical Sign Distribution Agreement for Implant Stability Tool
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Ambiq Wins IoT Semiconductor Company of the Year Award
    Ynvisible Names Michael Robinson CEO, Jani-Mikael Kuusisto SVP Ventures

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login